DE60323105D1 - Verfahren zur beseitigung von störungen in immunochromatographischen assays - Google Patents

Verfahren zur beseitigung von störungen in immunochromatographischen assays

Info

Publication number
DE60323105D1
DE60323105D1 DE60323105T DE60323105T DE60323105D1 DE 60323105 D1 DE60323105 D1 DE 60323105D1 DE 60323105 T DE60323105 T DE 60323105T DE 60323105 T DE60323105 T DE 60323105T DE 60323105 D1 DE60323105 D1 DE 60323105D1
Authority
DE
Germany
Prior art keywords
antibody
analyte
specific binding
capture region
binding pair
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60323105T
Other languages
English (en)
Inventor
Ronald G Sommer
Lloyd S Schulman
Daya C Wijesuriya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics Inc
Original Assignee
Siemens Healthcare Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=30443200&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60323105(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Siemens Healthcare Diagnostics Inc filed Critical Siemens Healthcare Diagnostics Inc
Application granted granted Critical
Publication of DE60323105D1 publication Critical patent/DE60323105D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B38/00—Porous mortars, concrete, artificial stone or ceramic ware; Preparation thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/97—Test strip or test slide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/81—Tube, bottle, or dipstick
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Ceramic Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Structural Engineering (AREA)
  • Organic Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE60323105T 2002-07-19 2003-06-04 Verfahren zur beseitigung von störungen in immunochromatographischen assays Expired - Lifetime DE60323105D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/198,890 US7108993B2 (en) 2002-07-19 2002-07-19 Use of dual conjugated labels in the elimination of serum interference in immunochromatographic assays
PCT/US2003/017689 WO2004010142A1 (en) 2002-07-19 2003-06-04 Method for the elimination of interferences in immunochromatographic assays

Publications (1)

Publication Number Publication Date
DE60323105D1 true DE60323105D1 (de) 2008-10-02

Family

ID=30443200

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60323105T Expired - Lifetime DE60323105D1 (de) 2002-07-19 2003-06-04 Verfahren zur beseitigung von störungen in immunochromatographischen assays

Country Status (8)

Country Link
US (1) US7108993B2 (de)
EP (1) EP1540343B1 (de)
AT (1) ATE405830T1 (de)
AU (1) AU2003248619A1 (de)
CA (1) CA2492090A1 (de)
DE (1) DE60323105D1 (de)
ES (1) ES2309353T3 (de)
WO (1) WO2004010142A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1659407A1 (de) * 2004-11-19 2006-05-24 Norwegian Antibodies AS Diagnose-Steuerungssystem
US20080286807A1 (en) * 2005-11-21 2008-11-20 Oregon Health & Science University Methods and Reagents for Elimination or Reduction of False Positives in the Analysis of a Sample
NL1033365C2 (nl) 2007-02-09 2008-08-12 Medavinci Dev B V Inrichting en werkwijze voor scheiden en analyseren van bloed.
NL2001577C2 (nl) * 2008-05-14 2009-11-17 Medavinci Dev B V Inrichting en werkwijze voor scheiden en analyseren van bloed.
US8084272B2 (en) * 2009-03-25 2011-12-27 Abbott Point Of Care Inc. Amelioration of heterophile antibody immunosensor interference
US20100317033A1 (en) * 2009-06-10 2010-12-16 Matthew Philip Abdel Methods and materials for detecting food containing allergens
KR101291245B1 (ko) * 2009-11-27 2013-07-30 한국전자통신연구원 미세유체제어 칩 및 미세유체제어 칩에서의 단백질 검출 방법
CN106574223B (zh) 2014-04-02 2019-11-01 生化诊断系统公司 利用俘获缀合物的免疫测定
CN104020289B (zh) * 2014-06-23 2015-09-30 宁波艾科生物科技有限公司 一种筛选抗原不同结合位点的单克隆抗体的方法
CN112129955B (zh) * 2019-06-25 2023-04-07 迈克生物股份有限公司 睾酮检测试剂盒

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7807532A (nl) 1978-07-13 1980-01-15 Akzo Nv Metaal-immunotest.
US4282287A (en) 1980-01-24 1981-08-04 Giese Roger W Biochemical avidin-biotin multiple-layer system
US4446232A (en) 1981-10-13 1984-05-01 Liotta Lance A Enzyme immunoassay with two-zoned device having bound antigens
US4752638A (en) 1983-11-10 1988-06-21 Genetic Systems Corporation Synthesis and use of polymers containing integral binding-pair members
US4806311A (en) 1985-08-28 1989-02-21 Miles Inc. Multizone analytical element having labeled reagent concentration zone
US4868108A (en) 1985-12-12 1989-09-19 Hygeia Sciences, Incorporated Multiple-antibody detection of antigen
US5096809A (en) * 1988-07-25 1992-03-17 Pacific Biotech, Inc. Whole blood assays using porous membrane support devices
US5079174A (en) 1988-12-08 1992-01-07 Boehringer Mannheim Corporation Apparatus for sequential determination of an analyte in a fluid sample
US5234812A (en) 1988-12-08 1993-08-10 Boehringer Mannheim Corporation Method for sequential determination of an analyte in a fluid sample using a third receptor
DE3915135A1 (de) 1989-05-09 1990-11-15 Boehringer Mannheim Gmbh Verfahren zum nachweis spezifisch bindefaehiger substanzen in koerperfluessigkeiten
US5252496A (en) * 1989-12-18 1993-10-12 Princeton Biomeditech Corporation Carbon black immunochemical label
US5141850A (en) * 1990-02-07 1992-08-25 Hygeia Sciences, Inc. Porous strip form assay device method
US5210017A (en) * 1990-11-19 1993-05-11 Genentech, Inc. Ligand-mediated immunofunctional hormone binding protein assay method
US5296347A (en) * 1991-02-08 1994-03-22 Ciba Corning Diagnostics Corp. Bridge immunoassay
US5445936A (en) * 1993-09-15 1995-08-29 Ciba Corning Diagnostics Corp. Method for non-competitive binding assays
US5569608A (en) * 1995-01-30 1996-10-29 Bayer Corporation Quantitative detection of analytes on immunochromatographic strips
US6924153B1 (en) * 1997-03-06 2005-08-02 Quidel Corporation Quantitative lateral flow assays and devices
US6146836A (en) * 1997-05-19 2000-11-14 Bayer Corporation Immunoassays using anti-allotypic monoclonal antibodies
US6087184A (en) * 1997-11-10 2000-07-11 Beckman Coulter, Inc. Opposable-element chromatographic assay device for detection of analytes
US6194222B1 (en) * 1998-01-05 2001-02-27 Biosite Diagnostics, Inc. Methods for monitoring the status of assays and immunoassays
SE9801563D0 (sv) * 1998-04-30 1998-04-30 Pharmacia & Upjohn Diag Ab Förfarande med separation och kit att användas vid förfarandet
US6180417B1 (en) * 1999-04-22 2001-01-30 Bayer Corporation Immunochromatographic assay
US6680209B1 (en) * 1999-12-06 2004-01-20 Biosite, Incorporated Human antibodies as diagnostic reagents
US6764825B1 (en) * 2000-10-13 2004-07-20 Tang J. Wang Methods and device for detecting prostate specific antigen (PSA)

Also Published As

Publication number Publication date
ES2309353T3 (es) 2008-12-16
US7108993B2 (en) 2006-09-19
EP1540343A4 (de) 2006-07-26
EP1540343A1 (de) 2005-06-15
ATE405830T1 (de) 2008-09-15
EP1540343B1 (de) 2008-08-20
CA2492090A1 (en) 2004-01-29
WO2004010142A1 (en) 2004-01-29
AU2003248619A1 (en) 2004-02-09
US20040014157A1 (en) 2004-01-22

Similar Documents

Publication Publication Date Title
ES2187622T3 (es) Reactivos y dispositivos de ensayo.
ES2151528T3 (es) Composicion de calibrador o control para un ensayo de serologia igm.
NO992578L (no) Antigenspesifikk IgG-deteksjon
BR9714365A (pt) Detecção de igm de antìgeno especìfico
DE60323105D1 (de) Verfahren zur beseitigung von störungen in immunochromatographischen assays
CA2589054A1 (en) Detection of a therapeutic antibody in an experimental animal
NO172264C (no) Immunokjemisk ettrinns-fremgangsmaate for bestemmelse av et av immunoglobulinantistoffene a, m, d eller e samt reagens for utfoerelse av fremgangsmaate
ATE310956T1 (de) Festphasenverfahren und testsatz zur antigen- und antikörperprüfung in der blutgruppen-serologie
ATE511650T1 (de) Verfahren zum nachweis von antikörpern einer bestimmten klasse über einen immunkomplex spezifischen antikörper
WO2003046140A3 (en) Immunoassay and kit for an early and simulataneous detection of biochemical markers in a patient's sample
DE69819643D1 (de) Zwei-Inkubations mit markiertem Antigen verwendenes Immunoassay
DE58907087D1 (de) Verfahren zur Bestimmung von für ein Antigen klassenspezifischen Antikörpern und dazu geeignetes Reagenz.
ATE282830T1 (de) Immuntest für human chromogranine a (cga), antikörper, reagenz und dazu geeigneter testsatz
ATE462975T1 (de) Verfahren zum immunochemischen testen des anti- hm1.24-antikörpers
DE59205079D1 (de) Immunologisches Nachweisverfahren
DE69930843D1 (de) Verfahren zum bestimmen von autoantikörpern
ATE259065T1 (de) Verfahren zum nachweis von helicobacter pylori und heilmanii
ATE174688T1 (de) Verfahren zur bestimmung von antigenen oder antikörpern in gegenwart eines immunkomplexes
DE60138981D1 (de) Immunoassay für H. pylori in Fäkalienproben mit Hilfe von gattungsspezifischen Antikörpern
DE59906849D1 (de) Verfahren zum spezifischen Nachweis von glykosilierten Proteinen
ATE336513T1 (de) Antikörper, die spezifisch für freies inaktives psa sind, und ihre verwendungen
CA2513271A1 (en) Generic method for latex agglutination assays
DE59007046D1 (de) Verfahren zum Nachweis von Analyten.
ATE315785T1 (de) Verfahren und diagnostikum zum qualitativen oder quantitativen nachweis von antikörpern und zur bestimmung von deren avidität

Legal Events

Date Code Title Description
8363 Opposition against the patent